Bevacizumab for advanced breast cancer

被引：20
作者：
Traina, Tiffany A.
Rugo, Hope S.
Dickler, Maura
机构：
[1] Mem Sloan Kettering Canc Ctr, Dept Med, Breast Canc Med Serv, New York, NY 10021 USA
[2] Univ Calif San Francisco, Ctr Comprehens Canc, Breast Oncol Clin Trials Program, San Francisco, CA 94143 USA
来源：
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 2007年 / 21卷 / 02期
关键词：
D O I：
10.1016/j.hoc.2007.03.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Tumor angiogenesis is essential for the growth and metastasis of solid tumors. In breast cancer, increased levels of vascular endothelial growth factor (VEGF) have been associated with poor prognosis in lymph nodepositive and lymph node-negative patients. In addition to its prognostic significance, VEGF is now a validated target in the treatment of breast cancer. Bevacizumab, an anti-VEGF antibody, has demonstrated significant clinical benefit in several solid tumors. In this article the authors discuss the data pertaining to bevacizumab and other antiangiogenic agents for the treatment of patients who have advanced breast cancer.
引用
收藏
页码：303 / +
页数：18
相关论文
共 67 条
[1]   Acute temporal regulation of vascular endothelial growth/permeability factor expression and endothelial morphology in the baboon endometrium by ovarian steroids [J].
Albrecht, ED ;
Aberdeen, GW ;
Niklaus, AL ;
Babischkin, JS ;
Suresch, DL ;
Pepe, GJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) :2844-2852
[2]  
Belotti D, 1996, CLIN CANCER RES, V2, P1843
[3]  
BERNSTEIN JA, 2006, J CLIN ONCOL, P24
[4]  
Borgström P, 1998, PROSTATE, V35, P1
[5]  
Borgström P, 1999, ANTICANCER RES, V19, P4203
[6]  
BURGER R, 2005, 2005 ASCO ANN M ORL
[7]  
BURSTEIN H, 2005, BREAST CANC RES T S1, V94
[8]  
Burstein HJ, 2002, BREAST CANCER RES TR, V76, pS115
[9]   A phase I/II dose-escalation trial of bevacizumab in previously treated metastatic breast cancer [J].
Cobleigh, MA ;
Langmuir, VK ;
Sledge, GW ;
Miller, KD ;
Haney, L ;
Novotny, WF ;
Reimann, JD ;
Vassel, A .
SEMINARS IN ONCOLOGY, 2003, 30 (05) :117-124
[10]   VEGF-receptor signal transduction [J].
Cross, MJ ;
Dixelius, J ;
Matsumoto, T ;
Claesson-Welsh, L .
TRENDS IN BIOCHEMICAL SCIENCES, 2003, 28 (09) :488-494
1234567